Skip to main content
Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
458.12
-7.22 (-1.55%)
At close: Dec 5, 2025, 4:00 PM EST
451.16
-6.96 (-1.52%)
After-hours: Dec 5, 2025, 7:40 PM EST

Alnylam Pharmaceuticals Employees

Alnylam Pharmaceuticals had 2,230 employees as of December 31, 2024. The number of employees increased by 130 or 6.19% compared to the previous year.

Employees
2,230
Change (1Y)
130
Growth (1Y)
6.19%
Revenue / Employee
$1,439,493
Profits / Employee
$19,536
Market Cap
60.52B

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 20242,2301306.19%
Dec 31, 20232,100984.90%
Dec 31, 20222,00233720.24%
Dec 31, 20211,66521214.59%
Dec 31, 20201,4531309.83%
Dec 31, 20191,32325824.23%
Dec 31, 20181,06531642.19%
Dec 31, 201774923545.72%
Dec 31, 201651414539.30%
Dec 31, 201536911344.14%
Dec 31, 20142569155.15%
Dec 31, 20131653627.91%
Dec 31, 20121291311.21%
Dec 31, 2011116-56-32.56%
Dec 31, 2010172-6-3.37%
Dec 31, 200917884.71%
Dec 31, 20081704131.78%
Dec 31, 200712975.74%
Dec 31, 20061222829.79%
Dec 31, 2005942332.39%
Dec 31, 2004711118.33%
Dec 31, 200360--
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.

Related Stocks

Company Name Employees
UnitedHealth Group 400,000
Johnson & Johnson 138,100
Thermo Fisher Scientific 125,000
Abbott Laboratories 114,000
AstraZeneca 92,900
Novo Nordisk 77,349
Novartis AG 75,883
Merck & Co. 75,000
Employee Rankings

ALNY News

More News